NDC 0113-0306-52 - Good Sense Clear Lax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0113-0306
- Requested NDC
- 0113-0306-52
- Package NDCs from labels
- 0113-0306-02, 0113-0306-03, 0113-0306-01, 0113-0306-17, 0113-0306-19, 0113-0306-18, 0113-0306-09, 0113-0306-52
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-01-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Perrigo ClearLax ® Drug Facts | Preferred Pharmaceuticals Inc. | 2026-01-23 | HUMAN OTC DRUG LABEL |
| Good Sense Clear Lax - L. Perrigo Company | L. Perrigo Company | 2023-01-24 | HUMAN OTC DRUG LABEL |
| Good Sense Clear Lax - Proficient Rx LP | Proficient Rx LP | 2022-07-01 | HUMAN OTC DRUG LABEL |
| Clearlax - Rebel Distributors Corp | Rebel Distributors Corp | 2011-01-12 | HUMAN OTC DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0113-0306-01 | Good Sense Clear Lax | 119 g in 1 BOTTLE | POWDER, FOR SOLUTION | 119 | 10 | |
| 0113-0306-02 | Good Sense Clear Lax | 238 g in 1 BOTTLE | POWDER, FOR SOLUTION | 238 | 10 | |
| 0113-0306-03 | Good Sense Clear Lax | 510 g in 1 BOTTLE | POWDER, FOR SOLUTION | 510 | 10 | |
| 0113-0306-09 | Good Sense Clear Lax | 765 g in 1 BOTTLE | POWDER, FOR SOLUTION | 765 | 10 | |
| 0113-0306-17 | Good Sense Clear Lax | 289 g in 1 BOTTLE | POWDER, FOR SOLUTION | 289 | 10 | |
| 0113-0306-18 | Good Sense Clear Lax | 153 g in 1 BOTTLE | POWDER, FOR SOLUTION | 153 | 10 | |
| 0113-0306-19 | Good Sense Clear Lax | 595 g in 1 BOTTLE | POWDER, FOR SOLUTION | 595 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0113-0306-01 | GM - Gram | 0113-0306 | ce121c50-d58c-4534-81ab-42dab967ca19 | 1 | 2012-07-24 |
| 0113-0306-02 | GM - Gram | 0113-0306 | 39f9d542-8248-4f3c-aeb1-921dca2e57ba | 1 | 2012-07-24 |
| 0113-0306-03 | GM - Gram | 0113-0306 | ab1c9984-a38c-487b-be98-730cd619a5d0 | 1 | 2012-07-24 |
| 0113-0306-17 | GM - Gram | 0113-0306 | 3013694b-c3d0-4635-a25e-b27bb7757f5d | 1 | 2019-04-11 |
| 0113-0306-19 | GM - Gram | 0113-0306 | 4cb8a239-6455-498a-9b70-901e2cc5a1a9 | 1 | 2019-04-11 |
| 0113-0306-52 | EA - Each | 0113-0306 | b2e6a93a-5e60-44a7-b1ff-f6c206acc8a5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL 3350 | ACTIVE INGREDIENT | G2M7P15E5P | GOOD SENSE CLEAR LAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [L. PERRIGO COMPANY] | 4 | |
| POLYETHYLENE GLYCOL 3350 | ACTIVE MOIETY | G2M7P15E5P | GOOD SENSE CLEAR LAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [L. PERRIGO COMPANY] | 4 | |
| POLYETHYLENE GLYCOL 3350 | ACTIVE INGREDIENT | G2M7P15E5P | CLEARLAX (POLYETHYLENE GLYCOL) POWDER, FOR SOLUTION [REBEL DISTRIBUTORS CORP] | 1 | |
| POLYETHYLENE GLYCOL 3350 | ACTIVE MOIETY | G2M7P15E5P | CLEARLAX (POLYETHYLENE GLYCOL) POWDER, FOR SOLUTION [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Atlantic Biologicals Corp. | 4c207478-6f0f-c3cf-e063-6394a90aa4f2 | 2026-06-04 | Warnings | 876193 G2M7P15E5P |
| Polyethylene glycol 3350 | POLYETHYLENE GLYCOL 3350 | Major Pharmaceuticals | ddc9d2b1-87d8-44fa-bac6-0a7261f33564 | 2026-05-12 | Warnings | 876193 G2M7P15E5P |
| smooth lax | POLYETHYLENE GLYCOL 3350 | Walgreen Company | 3027af65-2f7f-472d-83f5-254d5d75013c | 2026-05-08 | Warnings | ANDA090685 876193 G2M7P15E5P |
| MiraLAX | POLYETHYLENE GLYCOL 3350 | Bayer HealthCare LLC. | d69ce3d4-7ca4-4fe3-b49e-6655e48d6963 | 2026-05-04 | Warnings | 876193 G2M7P15E5P |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals, Inc. | 21654def-5ae0-422d-961b-1fe2456af00a | 2026-05-04 | Warnings | 876193 G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | CARDINAL HEALTH 110, LLC. DBA LEADER | 04cc4f2e-1725-4710-8cfb-73a6bdf52e4f | 2026-04-23 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurobindo Pharma Limited | b51f2223-8266-4d6c-bf32-58e53e73b54d | 2026-04-23 | Warnings | 876193 G2M7P15E5P |
| COMFORTLAX | POLYETHYLENE GLYCOL 3350 | Family Dollar Stores, LLC | 02a44a41-0039-f6ec-e063-6394a90ae6f1 | 2026-04-23 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurohealth LLC | d3c77f3f-57aa-4e2d-88aa-731cbb22af70 | 2026-04-23 | Warnings | 876193 G2M7P15E5P |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | G2M7P15E5P |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | G2M7P15E5P |
| clear lax | POLYETHYLENE GLYCOL 3350 | Meijer Distribution Inc | 6464f12c-0883-46c5-943b-a84fe235588e | 2026-04-13 | Warnings | ANDA090685 880407 876193 G2M7P15E5P |
| Polyethylene Glycol (3350) | POLYETHYLENE GLYCOL (3350) | Mylan Institutional Inc. | 219bcbc4-b84a-4209-9f34-ef2b0ef0d273 | 2026-04-08 | Warnings | 876193 |
| equate clear lax | POLYETHYLENE GLYCOL 3350 | Wal-Mart Stores Inc | 56a507f3-0cd1-4f02-9dfd-de297ba4bc1f | 2026-03-27 | Warnings | ANDA090685 880407 876193 G2M7P15E5P |
| foster and thrive clearlax | POLYETHYLENE GLYCOL 3350 | Strategic Sourcing Services LLC | 684e35cc-5a4f-458d-b5e7-e1933fea1139 | 2026-03-07 | Warnings | ANDA090685 880407 876193 G2M7P15E5P |
| ez2go Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Valley Medical Products, LLC | d64517d6-b0cc-4ba2-b260-e52faa8d4e78 | 2026-02-20 | Warnings | 876193 G2M7P15E5P |
| Topcare ClearLax | POLYETHYLENE GLYCOL 3350 | Topco Associates LLC | 03291fd3-7b64-4b79-ad84-e1b9b30a6b03 | 2026-02-19 | Warnings | ANDA090685 880407 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | American Health Packaging | 81374641-e54c-4b41-a3ad-49b19a097666 | 2026-02-18 | Warnings | 876193 G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.